Comprehensive study of the interplay between immunological and metabolic factors in hepatic steatosis
International Immunopharmacology · 2024
DOI: 10.1016/j.intimp.2024.112091 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Arnab Banerjee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology (UG & PG), Serampore College, 9 William Carey Road, Serampore, Hooghly 712201, West Bengal, India. Electronic address: arnab…. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 70 Literaturangaben.
Abstract (Originalsprache)
The pathophysiology of hepatic steatosis is thoroughly reviewed in this comprehensive report, with particular attention to the complex interactions between inflammatory pathways, insulin resistance, lipid metabolism, metabolic dysregulation, and immunological responses in the liver including non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), and hepatocellular carcinoma (HCC). The study highlights the role of immune cell regulation in disease progression and explores the potential of immune cell-specific treatments for treating hepatic disorders. The development of liver disorders is significantly influenced by immune cells, including dendritic cells, T cells, and natural killer cells. Clinical investigations show that immune cell-specific treatments can effectively reduce liver fibrosis and inflammation. Future research should focus on finding new immunological targets for therapeutic interventions, as well as addressing the management challenges associated with NAFLD/NASH. Hepatic immune microorganisms also impact liver homeostasis and disorders. Improvements in immune cell regulation and liver transplantation methods give patients hope for better prognoses. Important phases include optimizing the selection of donors for malignancy of the liver, using machine perfusion for organ preservation, and fine-tuning immunosuppressive strategies. For focused treatments in hepatic steatosis, it is imperative to understand the intricate interactions between immune and metabolic variables. Understanding the liver's heterogeneous immune profile, encompassing a range of immune cell subpopulations, is crucial for formulating focused therapeutic interventions. To improve patient care and outcomes in hepatic illnesses, there is an urgent need for further research and innovation. Therefore, to effectively treat hepatic steatosis, it is important to enhance therapeutic techniques and maximize liver transplantation strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Physiology (UG & PG), Serampore College, 9 William Carey Road, Serampore, Hooghly 712201, West Bengal, India. Electronic address: arnab.world10@gmail.com.
- Department of Physiology (UG & PG), Serampore College, 9 William Carey Road, Serampore, Hooghly 712201, West Bengal, India.
- Department of Physiology (UG & PG), Serampore College, 9 William Carey Road, Serampore, Hooghly 712201, West Bengal, India. Electronic address: bm_scp@yahoo.in.
Zitieren
APA
Banerjee, A., Das, D., Mukherjee, S., & Maji, B. K. (2024). Comprehensive study of the interplay between immunological and metabolic factors in hepatic steatosis. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.112091
Vancouver
Banerjee A, Das D, Mukherjee S, Maji BK. Comprehensive study of the interplay between immunological and metabolic factors in hepatic steatosis. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.112091
BibTeX
@article{Banerjee2024,
author = {Banerjee, Arnab and Das, Debasmita and Mukherjee, Sandip and Maji, Bithin Kumar},
title = {Comprehensive study of the interplay between immunological and metabolic factors in hepatic steatosis},
journal = {International Immunopharmacology},
year = {2024},
doi = {10.1016/j.intimp.2024.112091}
}
EUVIMED